|
1
|
Schouten LJ, Rutten J, Huveneers HA and
Twijnstra A: Incidence of brain metastases in a cohort of patients
with carcinoma of the breast, colon, kidney, and lung and melanoma.
Cancer. 94:2698–2705. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pestalozzi BC: Brain metastases and
subtypes of breast cancer. Ann Oncol. 20:803–805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH,
Chang DY, Li H, Lin YC, Chang HK, Chao TC, et al: Distant
metastasis in triple-negative breast cancer. Neoplasma. 60:290–294.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Melhem-Bertrandt A, Chavez-Macgregor M,
Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD,
Hortobagyi GN and Gonzalez-Angulo AM: Beta-blocker use is
associated with improved relapse-free survival in patients with
triple-negative breast cancer. J Clin Oncol. 29:2645–2652. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barron TI, Connolly RM, Sharp L, Bennett K
and Visvanathan K: Beta blockers and breast cancer mortality: A
population-based study. J Clin Oncol. 29:2635–2644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Powe DG, Voss MJ, Zänker KS, Habashy HO,
Green AR, Ellis IO and Entschladen F: Beta-blocker drug therapy
reduces secondary cancer formation in breast cancer and improves
cancer specific survival. Oncotarget. 1:628–638. 2010. View Article : Google Scholar
|
|
7
|
Neman J, Termini J, Wilczynski S, Vaidehi
N, Choy C, Kowolik CM, Li H, Hambrecht AC, Roberts E and Jandial R:
Human breast cancer metastases to the brain display GABAergic
properties in the neural niche. Proc Natl Acad Sci USA.
111:984–989. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Termini J, Neman J and Jandial R: Role of
the neural niche in brain metastatic cancer. Cancer Res.
74:4011–4015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
10
|
Purves D, Augustine GJ, Fitzpatrick D,
Katz LC, LaMantia AS, McNamara JO and Williams SM: Neuroscience.
2nd edition. Sinauer Associates; Sunderland, MA: 2001
|
|
11
|
Schuller HM and Cole B: Regulation of cell
proliferation by beta-adrenergic receptors in a human lung
adenocarcinoma cell line. Carcinogenesis. 10:1753–1755. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G,
Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, et al:
Surgical stress promotes tumor growth in ovarian carcinoma. Clin
Cancer Res. 15:2695–2702. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sloan EK, Priceman SJ, Cox BF, Yu S,
Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas
BD, Wu L, et al: The sympathetic nervous system induces a
metastatic switch in primary breast cancer. Cancer Res.
70:7042–7052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang XY, Wang HC, Yuan Z, Huang J and
Zheng Q: Norepinephrine stimulates pancreatic cancer cell
proliferation, migration and invasion via β-adrenergic
receptor-dependent activation of P38/MAPK pathway.
Hepatogastroenterology. 59:889–893. 2012.
|
|
15
|
Strell C, Niggemann B, Voss MJ, Powe DG,
Zanker KS and Entschladen F: Norepinephrine promotes the
β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular
endothelium by the induction of a GROα release. Mol Cancer Res.
10:197–207. 2012. View Article : Google Scholar
|
|
16
|
Gottschalk A, Sharma S, Ford J, Durieux ME
and Tiouririne M: Review article: The role of the perioperative
period in recurrence after cancer surgery. Anesth Analg.
110:1636–1643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Benish M, Bartal I, Goldfarb Y, Levi B,
Avraham R, Raz A and Ben-Eliyahu S: Perioperative use of
beta-blockers and COX-2 inhibitors may improve immune competence
and reduce the risk of tumor metastasis. Ann Surg Oncol.
15:2042–2052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sood AK, Bhatty R, Kamat AA, Landen CN,
Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S and Cole SW:
Stress hormone-mediated invasion of ovarian cancer cells. Clin
Cancer Res. 12:369–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D
and Zhang M: Norepinephrine-induced invasion by pancreatic cancer
cells is inhibited by propranolol. Oncol Rep. 22:825–830.
2009.PubMed/NCBI
|
|
20
|
Marchesi F, Monti P, Leone BE, Zerbi A,
Vecchi A, Piemonti L, Mantovani A and Allavena P: Increased
survival, proliferation, and migration in metastatic human
pancreatic tumor cells expressing functional CXCR4. Cancer Res.
64:8420–8427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Entschladen F, Drell TL IV, Lang K, Joseph
J and Zaenker KS: Tumour-cell migration, invasion, and metastasis:
Navigation by neurotransmitters. Lancet Oncol. 5:254–258. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang J, Li Z, Lu L and Cho CH:
β-adrenergic system, a backstage manipulator regulating tumour
progression and drug target in cancer therapy. Semin Cancer Biol.
23:533–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, et al: Chronic stress promotes tumor growth and angiogenesis in
a mouse model of ovarian carcinoma. Nat Med. 12:939–944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gille E, Lemoine H, Ehle B and Kaumann AJ:
The affinity of (-)-propranolol for beta 1- and beta
2-adrenoceptors of human heart. Differential antagonism of the
positive inotropic effects and adenylate cyclase stimulation by
(-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch
Pharmacol. 331:60–70. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masur K, Niggemann B, Zanker KS and
Entschladen F: Norepinephrine-induced migration of SW 480 colon
carcinoma cells is inhibited by beta-blockers. Cancer Res.
61:2866–2869. 2001.PubMed/NCBI
|
|
26
|
Drell TL IV, Joseph J, Lang K, Niggemann
B, Zaenker KS and Entschladen F: Effects of neurotransmitters on
the chemokinesis and chemotaxis of MDA-MB-468 human breast
carcinoma cells. Breast Cancer Res Treat. 80:63–70. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lucin KM, Sanders VM and Popovich PG:
Stress hormones collaborate to induce lymphocyte apoptosis after
high level spinal cord injury. J Neurochem. 110:1409–1421. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pérez Piñero C, Bruzzone A, Sarappa MG,
Castillo LF and Lüthy IA: Involvement of α2- and β2-adrenoceptors
on breast cancer cell proliferation and tumour growth regulation.
Br J Pharmacol. 166:721–736. 2012. View Article : Google Scholar
|
|
29
|
Zhang D, Ma QY, Hu HT and Zhang M:
β2-adrenergic antagonists suppress pancreatic cancer cell invasion
by inhibiting CREB, NFκB and AP-1. Cancer Biol Ther. 10:19–29.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lang K and Bastian P: Neurotransmitter
effects on tumor cells and leukocytes. Prog Exp Tumor Res.
39:99–121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carie AE and Sebti SM: A chemical biology
approach identifies a beta-2 adrenergic receptor agonist that
causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2
pathway. Oncogene. 26:3777–3788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Badino GR, Novelli A, Girardi C and Di
Carlo F: Evidence for functional beta-adrenoceptor subtypes in CG-5
breast cancer cell. Pharmacol Res. 33:255–260. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palm D, Lang K, Niggemann B, Drell TL IV,
Masur K, Zaenker KS and Entschladen F: The norepinephrine-driven
metastasis development of PC-3 human prostate cancer cells in
BALB/c nude mice is inhibited by beta-blockers. Int J Cancer.
118:2744–2749. 2006. View Article : Google Scholar
|
